Aging Population And Licensing Wins Will Redefine Dermatology
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
27 Jul 25
Updated
21 Aug 25
AnalystHighTarget's Fair Value
CA$20.00
24.5% undervalued intrinsic discount21 Aug
CA$15.10
1Y
-11.0%7D
4.2%